找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Concomitant Continuous Infusion Chemotherapy and Radiation; Marvin Rotman (Professor and Chairman, Dept. of Ra Textbook 1991 Springer-Verl

[復(fù)制鏈接]
樓主: mobility
51#
發(fā)表于 2025-3-30 11:31:35 | 只看該作者
52#
發(fā)表于 2025-3-30 13:41:27 | 只看該作者
53#
發(fā)表于 2025-3-30 20:04:08 | 只看該作者
Strategies for Overcoming Challenges,ally hypoxic cells thought to exist in many human tumors. A recent study examining the patterns of failure following radiation treatment for high grade brain tumors revealed that 78% of unifocal tumors recurred within 2 cm of the enhancing edge of the tumor, as demonstrated by the CT scan (W. et al.
54#
發(fā)表于 2025-3-30 21:59:17 | 只看該作者
55#
發(fā)表于 2025-3-31 01:06:03 | 只看該作者
56#
發(fā)表于 2025-3-31 08:05:01 | 只看該作者
Textbook 1991fects resulting from the administration of commonly used drugs, such as 5-fluorouracil, cisplatinum and adriamycin, with concomitant radiation therapy. Much of the data has never before been published. The wealth of information in this volume makes it a valuable reference; at the same time it gives
57#
發(fā)表于 2025-3-31 10:09:13 | 只看該作者
Experimental Rationale for Continuous Infusion Chemotherapydemonstrated the importance of dose intensity for optimal antineoplastic effect. The administration schedule required to achieve maximal dose intensity, however, is not the same for every drug. The pharmacodynamic response to any drug is a function of concentration and duration of exposure. The simp
58#
發(fā)表于 2025-3-31 14:08:48 | 只看該作者
Combination Chemotherapy by Infusion in Hematological Malignanciesnt of hematological malignancies. For the past decade our group has been interested in the use of infusional chemotherapy in the treatment of lymphomas. The following discussion will review our experiences and those of others in this area. We will also comment on work by other investigators on the u
59#
發(fā)表于 2025-3-31 20:58:53 | 只看該作者
60#
發(fā)表于 2025-4-1 00:31:46 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 07:38
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
石首市| 普定县| 阳原县| 永兴县| 栾城县| 本溪市| 大丰市| 黄龙县| 泸溪县| 五大连池市| 荣昌县| 凉城县| 石渠县| 高雄市| 卓资县| 合江县| 博兴县| 基隆市| 额济纳旗| 平罗县| 浦北县| 漾濞| 平安县| 奎屯市| 宁远县| 汶川县| 温宿县| 闸北区| 丰城市| 敦煌市| 昆明市| 牡丹江市| 富锦市| 武穴市| 日喀则市| 江西省| 霍州市| 大名县| 墨玉县| 柘荣县| 桦川县|